Full year 2023 key financials: Group net revenues of €783.5 million, including Jyseleca® net sales of €112.3 million Cash and current financial investments of € ...
People also ask
How big is Galapagos Pharma?
What is the turnover of Galapagos?
What is the earnings of Galapagos q3?
What does Galapagos NV do?
Press Releases. This section contains information about Galapagos NV's business for stockholders, potential investors, financial analysts and media.
Investor Relations – Filings and financial statements from Galapagos NV. Check out the latest publications, news and insider trades.
VP Investor Relations +1 781 460 1784. Sofie Van Gijsel Senior Director Investor Relations +1 781 296 1143. Sandra Cauwenberghs Director Investor Relations + ...
Feb 23, 2024 · ... Galapagos' full year 2023 results. I'm Sofie Van Gijsel, Investor Relations, representing the reporting team at Galapagos. This recorded ...
Mar 23, 2023 · NASDAQ: GLPG) today publishes its annual report for the financial year 2022 and announces its ... Investor relations. Marieke Vermeersch. Sofie ...
Galapagos NV American Depositary Shares is estimated to report earnings on 05/02/2024. The upcoming earnings date is derived from an algorithm based on a ...